- Home
- RCUS vs TWO Comparison
RCUS vs TWO Comparison
Compare RCUS & TWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- TWO
- Stock Information
- Founded
- RCUS 2015
- TWO 2009
- Country
- RCUS United States
- TWO United States
- Employees
- RCUS N/A
- TWO N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- TWO Real Estate Investment Trusts
- Sector
- RCUS Health Care
- TWO Real Estate
- Exchange
- RCUS Nasdaq
- TWO Nasdaq
- Market Cap
- RCUS 906.4M
- TWO 1.1B
- IPO Year
- RCUS 2018
- TWO 2009
- Fundamental
- Price
- RCUS $10.40
- TWO $10.09
- Analyst Decision
- RCUS Buy
- TWO Buy
- Analyst Count
- RCUS 8
- TWO 9
- Target Price
- RCUS $20.71
- TWO $12.94
- AVG Volume (30 Days)
- RCUS 783.0K
- TWO 1.9M
- Earning Date
- RCUS 08-06-2025
- TWO 07-28-2025
- Dividend Yield
- RCUS N/A
- TWO 15.46%
- EPS Growth
- RCUS N/A
- TWO N/A
- EPS
- RCUS N/A
- TWO N/A
- Revenue
- RCUS $262,000,000.00
- TWO $257,735,000.00
- Revenue This Year
- RCUS N/A
- TWO N/A
- Revenue Next Year
- RCUS $28.73
- TWO N/A
- P/E Ratio
- RCUS N/A
- TWO N/A
- Revenue Growth
- RCUS 6.07
- TWO N/A
- 52 Week Low
- RCUS $6.50
- TWO $9.67
- 52 Week High
- RCUS $18.98
- TWO $14.28
- Technical
- Relative Strength Index (RSI)
- RCUS 63.56
- TWO 48.76
- Support Level
- RCUS $9.73
- TWO $9.73
- Resistance Level
- RCUS $10.23
- TWO $10.26
- Average True Range (ATR)
- RCUS 0.53
- TWO 0.20
- MACD
- RCUS 0.07
- TWO 0.04
- Stochastic Oscillator
- RCUS 82.11
- TWO 70.34
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About TWO Two Harbors Investment Corp
Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, or RMBS; residential mortgage loans; mortgage servicing rights; and commercial real estate. The majority of the company's investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. Two Harbors derives nearly all of its revenue in the form of interest income collected from its investments. The majority of this income is generated by available-for-sale securities, while residential mortgage loans held for investment in securitization trusts also contribute a sizable amount.